Riding the VitaCig Inc OTCMKTS:VTCQ) Express 0
BY CARRIE RIVERS ON DECEMBER 7, 2015 MICRO CAP INSIDER, STREET WATCH
VitaCig Inc OTCMKTS:VTCQ) is making a highly explosive move up on accelerating volume, surging out of the subs well into penny land and transforming into one of the top traded stocks on the entire bb’s.
VTCQ is a brand new Nevada Corp that hit the bb’s in January of this year after being spun off from MCIG who currently owns a 47% stake in the Company.
VitaCig, Inc. (otc pink:VTCQ) bills itself as a technology Company harnessing mobile vaporization technology for medical delivery applications. The company owns, manufactures, and distributes the VitaCig(R), a nicotine-free device.
The VitaCig® device is designed to deliver the vapor of vitamins A,B,C,E, Coenzyme Q10, terpenes, and phytonutrients via direct inhalation. Phytonutrients and terpenes are compounds found in plants.
According to VTCQ The VitaCig® is the right product unveiled at the right time. By removing nicotine entirely from the equation and delivering vitamins, terpenes, and phytonutrients instead, VitaCig® is well-positioned to gain both the trust and acceptance of consumers around the world.
VitaCig, Inc. is disrupting both the traditional tobacco industry and the emerging personal vaporizer market by appealing to the 1.2 billion adults globally that smoke cigarettes. VitaCig(R) accomplishes this by providing a nicotine- and tobacco-free alternative that may assist in harm reduction.
The traditional tobacco industry is estimated at nearly $900 Billion a year. Financial analysts from Wells Fargo, Goldman Sachs, and Citigroup predict that by 2022 Electronic Cigarettes will supplant the traditional tobacco industry and eventually grow into a $1 Trillion industry.”
The Company is not big on pr’s; in July they said they signed a new Regional Sales Manager of Asia, which complements the existing South Korean initiative and will initially target the Philippines and Japan. This manager was heavily involved in the South Korean approval process and will use that experience as the Company expands VitaStik into additional Asian markets.
My posts are my opinions from due dilligence that I have personally performed courtesy of public financials and press releases. Trade at your own risk. Do not make any financial decisions based on anything that I write.
~867
